Effects of smoking on visual acuity of central serous chorioretinopathy patients

Cutaneous and Ocular Toxicology

Volumn 33, Issue 2, 2014, Pages 115-119

  Türkcü, Fatih Mehmet ^a   Yüksel, Harun ^a   Şahin, Alparslan ^a   Cinar, Yasin ^a   Cingü, Kürşat ^a   Ari, Şeyhmus ^a   Şahin, Muhammed ^a   Altindaǧ, Suat ^a   Çaça, Ihsan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

Central serous chorioretinopathy; Cigarette; Smoking

Indexed keywords

BEVACIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL SEROUS RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RECURRENCE RISK; RETINAL THICKNESS; RETROSPECTIVE STUDY; SMOKING; TURKEY (REPUBLIC); VISUAL ACUITY; CENTRAL SEROUS CHORIORETINOPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; YOUNG ADULT;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CENTRAL SEROUS CHORIORETINOPATHY; FEMALE; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SMOKING; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 84901310208     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2013.810633     Document Type: Article

References (40)

1. Haimovici R, Koh S, Gagnon DR, et al. Central serous chorioretinopathy case-control study group. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 2004;111:244-249.
2. Scheider A, Naseman JE, Lund OE. Fluoreseein and indocyanine green angiographies of central serous choriodopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 1993;115:50-56.
3. Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 2011;22: 166-173.
4. Fielding JE. Smoking: health effects and control. N Engl J Med 1985;313:491-498.
5. Wennmalm A. Effect of cigarette smoking on basal and carbon dioxide stimulated cerebral blood flow in man. Clin Physiol 1982; 2:529-535.
6. Ball K, Turner R. Smoking and the heart: the basis for action. Lancet 1974;7884:822-826.
7. Soldberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998;42: 535-547.
8. Congdon NG. Prevention strategies for age-related cataract: present limitations and future possibilities. Br J Ophthalmol 2001;85:516-520.
9. Mitchell P, Wang JJ, Smith W, et al. Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 2002;120:1357-1363.
10. Fraser-Bell S, Wu J, Klein R, et al. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006;141: 79-87.
11. Evans JR, Fletcher AE, Wormald RP. 28 000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005;89:550-553.
12. Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-141.
13. Chung SM, Gay CA, McCrary JA. Non-arteritic ischaemic optic neuropathy: the impact of tobacco use. Ophthalmology 1994;101: 779-782.
14. Shine B, Fells P, Adwards OM, et al. Association between Graves' ophthalmopathy and smoking. Lancet 1990;335:1261-1263.
15. Wilson MR, Ertzmark E, Walker AM, et al. A case-control study of risk factors in open-angle glaucoma. Arch Ophthalmol 1987; 105:1066-1071.
16. Lutty G, Grunwald J, Majji AB, et al. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis 2004;5:35.
17. Ciulla TA, Harris A, Kagemann L, et al. Choroid perfusion perturbations in nonneovascular age related macular degeneration. Br J Ophthalmol 2002;86:209-213.
18. Wennmalm A. Effect of cigarette smoking on basal and carbondioxide stimulated cerebral blood flow in man. Clin Physiol 1982;2:529-535.
19. Ball K, Turner R. Smoking and the heart. Lancet 1974;2:822-826.
20. Sarin CL, Austin JC, Nickel WO. Effects of smoking on digital blood-flow velocity. J Am Med Assoc 1974;229:1327-1328.
21. Lehtovirta P, Forss M. The acute effect of smoking on intervillous blood flow of the placenta. Br J Obstet Gynaecol 1978;85: 729-731.
22. Robinson F, Petrig BL, Riva CE. The acute effect of cigarette smoking on macular capillary blood flow in humans. Invest Ophthalmol Vis Sci 1985;26:609-613.
23. Hara K. Effect of cigarette smoking on ocular circulation. Immediate effect on retinal circulation. Folia Ophthalmol Jpn 1991;42:263-267.
24. Morgado PB, Chen HC, Patel V, et al. The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology 1994;101:1220-1226.
25. Steigerwalt Jr RD, Laurora G, Incandela L, et al. Ocular and orbital blood flow in cigarette smokers. Retina 2000;20:394-397.
26. Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996;103:2070-2079.
27. Chalon S, Moreno Jr H, Benowitz NL, et al. Nicotine impairs endothelium-dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000;67:391-397.
28. Gerzanich V, Zhang F, West GA, Simard JM. Chronic nicotine alters NO signaling of Ca2+ channels in cerebral arterioles. Circ Res 2001;88:359-365.
29. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001;20:227-253.
30. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, et al. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2004;45:311-317.
31. Maguire MG, Klein ML, Chamberlin JA. Recurrent choroid neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group. Arch Ophthalmol 1986;104:503-512.
32. Castro-Correia J, Coutinho MF, Rosas V, et al. Long-term follow up of central serous retinopathy in 150 patients. Doc Ophthalmol 1992;81:379-386.
33. Wang M, Munch IC. Central serous chorioretinopathy. Acta Opthalmol 2008;86:126-145.
34. Ascaso FJ, Rojo M, Minguez E, et al. Diagnostic and therapeutic challenges. Retina 2011;31:616-622.
35. Chan WM, Lam DS, Lai TY, et al. Choroid vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458.
36. Michels S, Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 2003;44: 2147-2154.
37. Watzke RC, Burton TC, Leaverton PE. Ruby laser photocoagulation therapy of central serous retinopathy. Trans Am Acad Ophthalmol Otolaryngol 1974;78:205-211.
38. Watzke RC, Burton TC, Woolson RF. Direct and indirect laser photocoagulation of central serous choroidopathy. Am J Ophthalmol 1979;88:914-918.
39. Gass JDM. Pathogenesis of disciform detachment of the neuroepithelium. II Idiopathic Central Serous Chorioretinopathy. Am J Opthalmol 1967;63:587-615.
40. Klein ML, Van Buskirk EM, Friedman E. Experience with nontreatment of central serous choroidopathy. Arch Opthalmol 1974;91:247-250.